Clinical and pregnancy characteristics | COVID-19- recovered patients | COVID-19-active patients | p-value |
---|---|---|---|
N = 92 | N = 84 | ||
Maternal age (years) | 30 (17–45) | 30 (20–44) | 0.965 |
Body mass index (kg/m2)* | 24.4 (17.9–40.1) | 23.5 (17.3–41) | 0.754 |
Gravidity | 3 (1–14) | 3 (1–12) | 0.761 |
Parity | 1.5 (0–10) | 2 (0–9) | 0.913 |
Nulliparity | 26 (28.26%) | 22 (26.19%) | 0.943 |
Multiparity | 10 (10.87%) | 10 (11.9%) | 0.943 |
Previous cesarean delivery | 14 (15.22%) | 14 (16.67%) | 0.839 |
Coexisting medical diseases | |||
Asthma | 2 (2.15%) | 1 (1.2%) | 1 |
Inflammatory bowel disease | 3 (3.26%) | 0 (0%) | 0.247 |
Diabetes mellitus | 3 (3.26%) | 2 (2.38%) | 1 |
Thyroid disease | 8 (8.7%) | 2 (2.38%) | 0.103 |
Chronic hypertension | 0 (0%) | 1 (1.19%) | 0.477 |
Anxiety disorder | 3 (3.26%) | 2 (2.38%) | 1 |
Antiphospholipid antibodies syndrome | 2 (2.17%) | 0 (0%) | 0.498 |
Chronic medication use | 16 (17.39) | 8 (9.52) | 0.186 |
Mode of conception | |||
Spontaneous | 87 (94.57%) | 79 (94.05%) | 0.724 |
Assisted reproduction | 5 (5.43%) | 3 (3.57%) | 0.724 |
Gestational diabetes mellitus | 13 (14.13%) | 15 (17.86%) | 0.541 |
Hypertensive disorders in pregnancy | 2 (2.17%) | 2 (2.38%) | 0.134 |